Form 4 for QURE uniQure N.V.
Accepted 2025-11-06 00:00:00 ET · period of report 2025-11-04 · accession 0000904454-25-000560 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-06 | 2025-11-04 | QURE | Kaye Jack | Dir | M - OptEx | $9.88 | +38.8K | 30.4K | New | +$383.5K |
| DM | 2025-11-06 | 2025-11-04 | QURE | Kaye Jack | Dir | S - Sale+OE | $30.34 | -38.8K | 20.4K | -66% | -$1.18M |
| DM | 2025-11-06 | 2025-11-04 | QURE | Kaye Jack | Dir | M - OptEx | $0.00 | -38.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-11-04 | M | A | 11,000 | $5.37 | 31,439 | D | — | — | |
| 2 | Common | Ordinary Shares | 2025-11-04 | S | D | 11,000 | $30.34 | 20,439 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.16 to $30.75. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Ordinary Shares | 2025-11-04 | S | D | 17,810 | $30.33 | 20,439 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.90. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Common | Ordinary Shares | 2025-11-04 | M | A | 17,810 | $14.08 | 38,249 | D | — | — | |
| 5 | Common | Ordinary Shares | 2025-11-04 | S | D | 10,000 | $30.36 | 20,439 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.20 to $30.79. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 6 | Common | Ordinary Shares | 2025-11-04 | M | A | 10,000 | $7.37 | 30,439 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2025-11-04 | M | D | 17,810 | $0.00 | 0 | D | $14.08 · — to 2032-06-15 | 17,810 Ordinary Shares | (F7) The Stock Option vested in full on June 15, 2023. |
| 8 | Derivative | Stock Option (Right to Buy) | 2025-11-04 | M | D | 11,000 | $0.00 | 0 | D | $5.37 · — to 2027-01-27 | 11,000 Ordinary Shares | (F6) The Stock Option vested in full on January 27, 2018. |
| 9 | Derivative | Stock Option (Right to Buy) | 2025-11-04 | M | D | 10,000 | $0.00 | 0 | D | $7.37 · — to 2027-06-29 | 10,000 Ordinary Shares | (F5) The Stock Option vested 25% on June 30, 2018 and 6.25% quarterly thereafter. |